OptiBiotix Health Plc (OPTI) - Total Assets
Based on the latest financial reports, OptiBiotix Health Plc (OPTI) holds total assets worth GBX9.15 Million GBX (≈ $1.11K USD) as of June 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See OptiBiotix Health Plc shareholders equity for net asset value and shareholders' equity analysis.
OptiBiotix Health Plc - Total Assets Trend (2008–2024)
This chart illustrates how OptiBiotix Health Plc's total assets have evolved over time, based on quarterly financial data.
OptiBiotix Health Plc - Asset Composition Analysis
Current Asset Composition (December 2024)
OptiBiotix Health Plc's total assets of GBX9.15 Million consist of 15.7% current assets and 84.3% non-current assets.
| Asset Category | Amount (GBX) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | GBX0.00 | 8.2% |
| Accounts Receivable | GBX433.00K | 4.8% |
| Inventory | GBX230.00K | 2.5% |
| Property, Plant & Equipment | GBX0.00 | 0.0% |
| Intangible Assets | GBX1.12 Million | 12.4% |
| Goodwill | GBX0.00 | 0.0% |
Asset Composition Trend (2008–2024)
This chart illustrates how OptiBiotix Health Plc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see OPTI market cap.
Key Asset Composition Facts
- Current vs. Non-Current Assets: OptiBiotix Health Plc's current assets represent 15.7% of total assets in 2024, a decrease from 100.0% in 2008.
- Cash Position: Cash and equivalents constituted 8.2% of total assets in 2024, down from 99.4% in 2008.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 12.0% of total assets, an increase from 0.0% in 2008.
- Asset Diversification: The largest asset category is intangible assets at 12.4% of total assets.
OptiBiotix Health Plc Competitors by Total Assets
Key competitors of OptiBiotix Health Plc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Argen-X
F:1AE
|
Germany | €7.18 Billion |
|
Tubize-Fin
BR:TUB
|
Belgium | €1.93 Billion |
|
BrightGene Bio Medical Technology C
SHG:688166
|
China | CN¥5.38 Billion |
|
Dashenlin Pharm Grp Co Ltd
SHG:603233
|
China | CN¥26.08 Billion |
|
Staidson Beijing Biopharma
SHE:300204
|
China | CN¥1.26 Billion |
|
Tibet Cheezheng Tibetan Medicine Co Ltd
SHE:002287
|
China | CN¥6.64 Billion |
|
Ardelyx Inc
NASDAQ:ARDX
|
USA | $486.17 Million |
|
Xiangxue Pharmaceutical
SHE:300147
|
China | CN¥7.36 Billion |
OptiBiotix Health Plc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 4.61 | 6.18 | 5.25 |
| Quick Ratio | 3.75 | 5.36 | 4.98 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | GBX1.66 Million | GBX1.62 Million | GBX1.78 Million |
OptiBiotix Health Plc - Advanced Valuation Insights
This section examines the relationship between OptiBiotix Health Plc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 0.71 |
| Latest Market Cap to Assets Ratio | 0.01 |
| Asset Growth Rate (YoY) | -3.8% |
| Total Assets | GBX9.04 Million |
| Market Capitalization | $64.10K USD |
Valuation Analysis
Below Book Valuation: The market values OptiBiotix Health Plc's assets below their book value (0.01x), which may indicate investor concerns about asset quality or future growth.
Slight Asset Contraction: OptiBiotix Health Plc's assets decreased by 3.8% over the past year, which may reflect streamlining or optimization of resources.
Annual Total Assets for OptiBiotix Health Plc (2008–2024)
The table below shows the annual total assets of OptiBiotix Health Plc from 2008 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | GBX9.04 Million ≈ $1.10K |
-3.82% |
| 2023-12-31 | GBX9.40 Million ≈ $1.14K |
-18.57% |
| 2022-12-31 | GBX11.55 Million ≈ $1.41K |
-42.67% |
| 2021-12-31 | GBX20.14 Million ≈ $2.45K |
+47.01% |
| 2020-12-31 | GBX13.70 Million ≈ $1.67K |
+101.75% |
| 2019-12-31 | GBX6.79 Million ≈ $826.40 |
-15.41% |
| 2018-11-30 | GBX8.03 Million ≈ $976.96 |
+4.70% |
| 2017-11-30 | GBX7.67 Million ≈ $933.12 |
+35.41% |
| 2016-11-30 | GBX5.66 Million ≈ $689.10 |
+29.55% |
| 2015-11-30 | GBX4.37 Million ≈ $531.93 |
-15.58% |
| 2014-11-30 | GBX5.18 Million ≈ $630.08 |
+1618.08% |
| 2013-11-30 | GBX301.42K ≈ $36.67 |
-64.11% |
| 2012-07-31 | GBX839.82K ≈ $102.18 |
+7.12% |
| 2010-07-31 | GBX784.00K ≈ $95.39 |
-4.62% |
| 2009-07-31 | GBX822.00K ≈ $100.01 |
-6.16% |
| 2008-07-31 | GBX876.00K ≈ $106.58 |
-- |
About OptiBiotix Health Plc
OptiBiotix Health Plc, a life sciences company, engages in the discovery and development of microbiome modulation products in the United Kingdom, the United States, India, China, and internationally. The company identifies and develops microbial strains, compounds, and formulations for use in food ingredients, supplements, and active compounds that can impact human physiology and derive potential… Read more